Solid STAIRWAY Leads Roche To Phase III Study Of Faricimab In Wet AMD Trial

 
• By Sten Stovall

Roche unveiled positive results from the Phase II STAIRWAY study which explored the extended durability of faricimab (RG7716) in the treatment of wet age-related macular degeneration (AMD).

Elderly woman
Wet AMD impacts the eye part that provides sharp, central vision • Source: Shutterstock

More from Sensory

More from Therapy Areas